Xenetic Biosciences (XBIO) Preferred Dividend Payments (2019)
Xenetic Biosciences' (XBIO) quarterly Preferred Dividend Payments came in at $1.4 million in Q3 2019, down 63.79% on a QoQ basis from $3.9 million in Q1 2019.
Xenetic Biosciences (XBIO) Preferred Dividend Payments (2019) Analysis & Trends
Xenetic Biosciences (XBIO) has 1 years of Preferred Dividend Payments data on file, last reported at $1.4 million in Q3 2019.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $1.4 million in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $1.4 million (down 63.79% YoY) and the FY2019 annual result came in at $5.3 million, changed N/A from the prior year.
- Preferred Dividend Payments slipped to $1.4 million in Q3 2019, from $3.9 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $3.9 million in Q1 2019 to a low of $1.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1.40 Mn |
| Mar 31, 2019 | 3.88 Mn |